|
Q: Who is Rexahn?
A: Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of innovative treatments for cancer, central nervous system disorders and other unmet medical needs. Our motto is "Saving Lives Through Innovation," which represents the Company's use of scientific innovation to improve the health and wellness of patients. We develop therapies that treat specific disease states, while minimizing side effects in order to help patients
regain quality of life during treatment.
Q: What is Rexahn¡¯s stock symbol?
A: The Company¡¯s common stock trades under the stock symbol RNN.
Q: What stock exchange is Rexahn listed on?
A: The Company¡¯s shares are listed on the American Stock Exchange.
Q: How many common shares of Rexahn are outstanding?
A: As of September 30, 2008 Rexahn had 56,025,649 shares outstanding.
Q: Where is Rexahn headquartered?
A: Rexahn Pharmaceuticals, Inc.
15245 Shady Grove Road, Suite 455
Rockville, MD 20850
Q: How many employees does Rexahn have?
A: As of September 30, the Company had approximately 15 full-time employees.
Q: How can I buy or sell Rexahn common stock?
A: The Company's common stock can be purchased or sold through any stock brokerage or discount brokerage firm.
Q: Does Rexahn offer a direct share purchase plan?
A: The Company does not offer a direct share purchase plan.
Q: Does Rexahn issue dividends or have a DRIP program?
A: The Company does not issue dividends or have a DRIP program.
Q: Who is Rexahn¡¯s transfer agent and how does a registered shareholder contact the agent regarding account information?
A: The transfer agent for the common stock is:
Olde Monmouth Stock Transfer Co Inc
200 Memorial Pkwy,
Atlantic Highlands,
NJ 07716-1655,
United States
Phone: 732-872-2727
Q: How can I access SEC documents such as a Form 10-KSB or 10-QSB?
A: Rexahn currently files these documents with the SEC, and make them available through this website (under Investor Relations/SEC Filings). These filings can also be found on the SEC¡¯s EDGAR website, and on several financial web pages.
Q: When is Rexahn¡¯s fiscal year end?
A: December 31st
Q: How do I contact Investor Relations?
A: If you can't find the information you're looking for on our website, please feel free to call or write us at:
|
